American Thyroid Association

This collection features commentaries, interviews, and slideshows developed by Medscape in collaboration with the American Thyroid Association. It is designed to advance the understanding of thyroid disorders and thyroid cancer, and to offer guidance to physicians, nurses, pharmacists, and the entire patient care team.

Editorial Collaboration

  • Surgery for Persistent Symptoms in Hashimoto's Thyroiditis? A recent study compared thyroidectomy with medical management for persistent symptoms of Hashimoto's thyroiditis. But is surgery really the answer?
  • Levothyroxine Dosing: Morning, Night, or In Between? Clinicians have traditionally told patients to take levothyroxine first thing in the morning, at least an hour before any food or drink. But does it really matter? Dr Leung looks at the evidence.
  • Thyroid Cancer in 2019: Questions That Remain Unanswered What used to be a relatively rare malignancy, thyroid cancer diagnoses are now rising quickly. Dr Leung discusses what we currently know and some of the top questions that remain unanswered.
  • The Love-Hate Relationship With Levothyroxine Levothyroxine, despite being the most prescribed drug in the United States, has many patients disenchanted and looking to T3 for symptom relief. How should clinicians approach the T4/T3 controversy?
  • The Thyroid Diet: Is There Such a Thing? From gluten to soy to iodine to selenium, patients are asking about 'thyroid diets.' What is the evidence on nutrition and thyroid health?


Transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community.